# Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria

> **NCT01378286** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 380 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** ARTESUNATE + AMODIAQUINE
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT01378286
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01378286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01378286, "Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01378286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*